Replies to post #10034 on CytoSorbents Corporation (CTSO)

[Early-One]

Sepsis & septic shock market to be worth $5.9 billion by 2026

The sepsis and septic shock space across the seven major pharmaceutical markets (7MM) of the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan is set to grow from $2.8 billion in 2016 to $5.9 billion by 2026, representing a compound annual growth rate (CAGR) of 7.9%, according to GlobalData, a recognized leader in providing business information and analytics.

(...)

Furthermore, two new first-in-class medical devices will be launched in the US over the next few years: Toraymyxin and CytoSorb.

https://www.linkedin.com/pulse/sepsis-septic-shock-market-worth-59-billion-2026-ritesh-das